Enhancing interoceptive awareness in chronic pain and opioid misuse via mindfulness-oriented recovery enhancement.
Anna Parisi, Lisa Taylor-Swanson, Jennifer L Stewart, Sahib S Khalsa, Eric L Garland
Drug and alcohol dependence June 2, 2025 DOI: 10.1016/j.drugalcdep.2025.112741 via PubMed
Summary
AI-generated from the abstractPeople with chronic pain who misuse opioids report lower awareness of internal bodily signals compared to those who take opioids as prescribed. In a study of 372 adults on long-term opioid therapy, lower scores on attention regulation and trusting one's body were linked to higher opioid misuse, even after accounting for pain severity. Among 250 participants at elevated risk, an 8-week mindfulness-based program (MORE) produced greater increases in interoceptive awareness than supportive group therapy, and these increases explained reductions in opioid misuse over nine months. The findings suggest that boosting interoceptive awareness may help reduce opioid misuse.
Study at a glance
| Characteristics | Randomized controlled trial Peer reviewed |
|---|---|
| Sample size | 372 |
| Population | Adults with chronic pain on long-term opioid therapy |
| Intervention | Mindfulness-Oriented Recovery Enhancement (MORE) |
| Duration | 8-week intervention, 9-month follow-up |
| Topics | Meditation |
| Keywords | Interoception Interoceptive awareness Opioid misuse treatment Opioid addiction treatment Opioid dependence management |
| Citations | 1 |
| Key finding | Lower interoceptive awareness was associated with higher opioid misuse at baseline, and a mindfulness-based intervention (MORE) increased interoceptive awareness, which mediated reductions in opioid misuse over nine months. |
Abstract
Individuals with substance use disorders often report altered interoceptive awareness of internal bodily signals. However, it is unclear whether these alterations also extend to patients with chronic pain who misuse opioids, and whether interventions that enhance interoceptive awareness, such as mindfulness-based therapies, may reduce opioid misuse in this population. At baseline, participants (N = 372) with chronic pain on long-term opioid therapy completed the Multidimensional Assessment of Interoceptive Awareness (MAIA), Current Opioid Misuse Measure (COMM), and the Brief Pain Inventory. A subset identified as having an elevated risk for opioid misuse (n = 250) were randomized to an 8 week Mindfulness-Oriented Recovery Enhancement (MORE) program or supportive group (SG) psychotherapy, and completed MAIA and COMM ratings through a 9-month follow-up period. At baseline, lower scores on the MAIA Attention Regulation and Trusting subscales were associated with higher levels of opioid misuse, even after accounting for pain severity and interference. MORE led to significantly greater increases in MAIA total and subscale scores (Attention Regulation, Trusting, and others) compared to SG, which mediated its effects on reducing opioid misuse over the 9-month follow-up period. Individuals with chronic pain who misuse opioids report lower interoceptive awareness than those using opioids as prescribed. By increasing interoceptive awareness, mindfulness-based interventions such as MORE may lessen the misuse of opioid analgesic medications. These findings suggest that interoceptive awareness is a promising intervention target for opioid misuse.